Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
Hosted on MSN24m
New FDA Approval Could Transform Pain ManagementIt’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...
Six-year-old Hassan Abed Raboh lives with an excruciating bladder condition that 25 operations at Gaza hospitals could not ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback